Profile
James H.
Davis worked as a Director at The Leukemia & Lymphoma Society, Inc. from 2007 to 2014.
He was also the Secretary, Executive VP & General Counsel at Human Genome Sciences, Inc. from 2010 to 2012.
Prior to that, he was a Partner at Weil, Gotshal & Manges LLP.
He served as Secretary, Vice President-Research & Development at Crop Genetics International Corp.
in 1995.
He was also Of Counsel at Finnegan, Henderson, Farabow, Garrett & Dunner LLP from 1995 to 1997.
Davis received his graduate degree from the University of Virginia, his undergraduate and graduate degrees from Yale University, and his doctorate from the California Institute of Technology.
Former positions of James H. Davis
| Companies | Position | End |
|---|---|---|
The Leukemia & Lymphoma Society, Inc.
 The Leukemia & Lymphoma Society, Inc. Miscellaneous Commercial ServicesCommercial Services The Leukemia & Lymphoma Society, Inc. operates as the world's largest voluntary health organization dedicated to funding blood cancer research, education and patient services. The firm provides treatment for , lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. It identifies and funds the most promising blood cancer research projects and forges partnerships with academic institutions, biotechnology and pharmaceutical companies to accelerate the development of new therapies. The company is headquartered in Rye Brook, NY. | Chairman | 2020-06-30 |
Human Genome Sciences, Inc.
 Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | General Counsel | 2012-07-29 |
Finnegan, Henderson, Farabow, Garrett & Dunner LLP
 Finnegan, Henderson, Farabow, Garrett & Dunner LLP Miscellaneous Commercial ServicesCommercial Services Finnegan, Henderson, Farabow, Garrett & Dunner LLP provides legal services. The firm practices all aspects of patent, trademark, copyright, and trade secret law including counseling, prosecution, licensing, and litigation. It represents clients on IP issues related to international trade, portfolio management, Internet, e-commerce, government contracts, antitrust, and unfair competition. The company was founded by Marcus Finnegan and Douglas Henderson on March 1, 1965 and is headquartered in Washington, DC. | Corporate Officer/Principal | 1996-12-31 |
Crop Genetics International Corp.
 Crop Genetics International Corp. Chemicals: AgriculturalProcess Industries Crop Genetics International Corp. provides agricultural chemicals and fertilizers. The company is based in Columbia, MD. Crop Genetics International was acquired by biosys, Inc. on March 31, 1995 for $11.38 million. | Chief Tech/Sci/R&D Officer | 1994-12-31 |
Weil, Gotshal & Manges LLP
 Weil, Gotshal & Manges LLP Miscellaneous Commercial ServicesCommercial Services Weil, Gotshal & Manges provides its clients with legal services. The firm offers services to areas including consumer, financial, government and non-profit, health care, industrial, and technology. The company was founded by Claude Serra in 1931 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
Training of James H. Davis
| University of Virginia | Graduate Degree |
| Yale University | Graduate Degree |
| California Institute of Technology | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Health Technology |
Weil, Gotshal & Manges LLP
Weil, Gotshal & Manges LLP Miscellaneous Commercial ServicesCommercial Services Weil, Gotshal & Manges provides its clients with legal services. The firm offers services to areas including consumer, financial, government and non-profit, health care, industrial, and technology. The company was founded by Claude Serra in 1931 and is headquartered in New York, NY. | Commercial Services |
Crop Genetics International Corp.
Crop Genetics International Corp. Chemicals: AgriculturalProcess Industries Crop Genetics International Corp. provides agricultural chemicals and fertilizers. The company is based in Columbia, MD. Crop Genetics International was acquired by biosys, Inc. on March 31, 1995 for $11.38 million. | Process Industries |
Finnegan, Henderson, Farabow, Garrett & Dunner LLP
Finnegan, Henderson, Farabow, Garrett & Dunner LLP Miscellaneous Commercial ServicesCommercial Services Finnegan, Henderson, Farabow, Garrett & Dunner LLP provides legal services. The firm practices all aspects of patent, trademark, copyright, and trade secret law including counseling, prosecution, licensing, and litigation. It represents clients on IP issues related to international trade, portfolio management, Internet, e-commerce, government contracts, antitrust, and unfair competition. The company was founded by Marcus Finnegan and Douglas Henderson on March 1, 1965 and is headquartered in Washington, DC. | Commercial Services |
The Leukemia & Lymphoma Society, Inc.
The Leukemia & Lymphoma Society, Inc. Miscellaneous Commercial ServicesCommercial Services The Leukemia & Lymphoma Society, Inc. operates as the world's largest voluntary health organization dedicated to funding blood cancer research, education and patient services. The firm provides treatment for , lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. It identifies and funds the most promising blood cancer research projects and forges partnerships with academic institutions, biotechnology and pharmaceutical companies to accelerate the development of new therapies. The company is headquartered in Rye Brook, NY. | Commercial Services |
- Stock Market
- Insiders
- James H. Davis
